APA (7th ed.) Citation

Yan, Q., Lin, H., Zhu, K., Cao, Y., Xu, X., Zhou, Z., . . . Zhang, R. (2022). Immune Checkpoint FGL1 Expression of Circulating Tumor Cells Is Associated With Poor Survival in Curatively Resected Hepatocellular Carcinoma. Frontiers in oncology, 12, 810269. https://doi.org/10.3389/fonc.2022.810269

Chicago Style (17th ed.) Citation

Yan, Qing, Hao-Ming Lin, Ke Zhu, Yi Cao, Xiao-Lin Xu, Zi-Yu Zhou, Lei-bo Xu, Chao Liu, and Rui Zhang. "Immune Checkpoint FGL1 Expression of Circulating Tumor Cells Is Associated With Poor Survival in Curatively Resected Hepatocellular Carcinoma." Frontiers in Oncology 12 (2022): 810269. https://doi.org/10.3389/fonc.2022.810269.

MLA (9th ed.) Citation

Yan, Qing, et al. "Immune Checkpoint FGL1 Expression of Circulating Tumor Cells Is Associated With Poor Survival in Curatively Resected Hepatocellular Carcinoma." Frontiers in Oncology, vol. 12, 2022, p. 810269, https://doi.org/10.3389/fonc.2022.810269.